Skip to main content
Erschienen in: Indian Journal of Hematology and Blood Transfusion 1/2016

27.01.2016 | Correspondence

Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report

verfasst von: Huseyin Saffet Bekoz, Bulent Kantarcioglu, Tulay Tecimer, Necdet Uskent, Mustafa Cetiner, Burhan Ferhanoglu, Deniz Sargin

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Sonderheft 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Burkitt lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma that has a high proliferation rate. The prognosis for BL is generally favorable, with cure rate of 75–90 % with modern chemoimmunotherapy regimens. Prompt administration of multiagent immunochemotherapy regimens is critical, because BL is almost always fatal if left untreated. Nevertheless here we report a case of BL that is still in complete remission after more than 4 years without any further treatment after surgical excision of the involved lymph node.
Literatur
2.
Zurück zum Zitat Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913–2920CrossRefPubMed Jacobson C, LaCasce A (2014) How I treat Burkitt lymphoma in adults. Blood 124(19):2913–2920CrossRefPubMed
5.
Zurück zum Zitat Bluming AZ, Ziegler JL (1971) Regression of Burkitt’s lymphoma in association with measles infection. Lancet 2(7715):105–106CrossRefPubMed Bluming AZ, Ziegler JL (1971) Regression of Burkitt’s lymphoma in association with measles infection. Lancet 2(7715):105–106CrossRefPubMed
6.
Zurück zum Zitat Sarkodee-Adoo C, Pittarelli L, Jaffe E, Sorbara L, Raffeld M, Yao X, Haddad R, Heller T (2001) Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma 42(5):1125–1131CrossRefPubMed Sarkodee-Adoo C, Pittarelli L, Jaffe E, Sorbara L, Raffeld M, Yao X, Haddad R, Heller T (2001) Regression and clonally distinct recurrence of human immunodeficiency virus related Burkitt-like lymphoma during antiretroviral therapy. Leuk Lymphoma 42(5):1125–1131CrossRefPubMed
7.
Zurück zum Zitat Parekh S, Hebert T, Ratech H, Sparano J (2005) Variable problems in lymphomas: CASE 3. Spontaneous regression of HIV-associated Burkitt’s lymphoma of the cecum. J Clin Oncol 23(31):8116–8117CrossRefPubMed Parekh S, Hebert T, Ratech H, Sparano J (2005) Variable problems in lymphomas: CASE 3. Spontaneous regression of HIV-associated Burkitt’s lymphoma of the cecum. J Clin Oncol 23(31):8116–8117CrossRefPubMed
8.
Zurück zum Zitat Baumgaertner I, Copie-Bergman C, Levy M, Haioun C, Charachon A, Baia M, Sobhani I, Delchier JC (2009) Complete remission of gastric Burkitt’s lymphoma after eradication of Helicobacter pylori. World J Gastroenterol 15(45):5746–5750CrossRefPubMedPubMedCentral Baumgaertner I, Copie-Bergman C, Levy M, Haioun C, Charachon A, Baia M, Sobhani I, Delchier JC (2009) Complete remission of gastric Burkitt’s lymphoma after eradication of Helicobacter pylori. World J Gastroenterol 15(45):5746–5750CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Costa LJ, Xavier AC, Wahlquist AE, Hill EG (2013) Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood 121(24):4861–4866CrossRefPubMedPubMedCentral Costa LJ, Xavier AC, Wahlquist AE, Hill EG (2013) Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood 121(24):4861–4866CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, Di Bona E, Oldani E, Parolini M, Gökbuget N, Bassan R (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 98(11):1718–1725CrossRefPubMedPubMedCentral Intermesoli T, Rambaldi A, Rossi G, Delaini F, Romani C, Pogliani EM, Pagani C, Angelucci E, Terruzzi E, Levis A, Cassibba V, Mattei D, Gianfaldoni G, Scattolin AM, Di Bona E, Oldani E, Parolini M, Gökbuget N, Bassan R (2013) High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program. Haematologica 98(11):1718–1725CrossRefPubMedPubMedCentral
Metadaten
Titel
Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report
verfasst von
Huseyin Saffet Bekoz
Bulent Kantarcioglu
Tulay Tecimer
Necdet Uskent
Mustafa Cetiner
Burhan Ferhanoglu
Deniz Sargin
Publikationsdatum
27.01.2016
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe Sonderheft 1/2016
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-016-0650-6

Weitere Artikel der Sonderheft 1/2016

Indian Journal of Hematology and Blood Transfusion 1/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.